MRTO4
mRNA turnover protein 4 homolog
Also known as: C1orf33, dJ657E11.4, MRT4, MRT4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UKD2
- Gene
- MRTO4
- Ensembl
- ENSG00000053372
- Chromosome
- 1
- Canonical length
- 239 aa
- Protein class
- Predicted intracellular proteins, Ribosomal proteins
- Subcellular location
- Nucleoplasm,Nuclear membrane,Nucleoli
OverviewNCBI Gene
This gene encodes a protein sharing a low level of sequence similarity with ribosomal protein P0. While the precise function of the encoded protein is currently unknown, it appears to be involved in mRNA turnover and ribosome assembly. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
239 residues, UniProt reviewed canonical sequence.
>Q9UKD2|MRTO4
1 MPKSKRDKKV SLTKTAKKGL ELKQNLIEEL RKCVDTYKYL FIFSVANMRN SKLKDIRNAW
61 KHSRMFFGKN KVMMVALGRS PSDEYKDNLH QVSKRLRGEV GLLFTNRTKE EVNEWFTKYT
121 EMDYARAGNK AAFTVSLDPG PLEQFPHSME PQLRQLGLPT ALKRGVVTLL SDYEVCKEGD
181 VLTPEQARVL KLFGYEMAEF KVTIKYMWDS QSGRFQQMGD DLPESASEST EESDSEDDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MRTO4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 26 nTPM
- pancreas: 25 nTPM
- cerebral cortex: 25 nTPM
- skeletal muscle: 24 nTPM
- amygdala: 23 nTPM
- hippocampal formation: 22 nTPM
Single-cell type
- esophageal basal cells: 128 nCPM
- erythrocyte progenitors: 90 nCPM
- migrating cytotrophoblasts: 89 nCPM
- late primary spermatocytes: 82 nCPM
- differentiating spermatogonia: 76 nCPM
- extravillous trophoblasts: 72 nCPM
Immune cell
- memory B-cell: 23 nTPM
- MAIT T-cell: 23 nTPM
- naive B-cell: 20 nTPM
- plasmacytoid DC: 20 nTPM
- naive CD4 T-cell: 19 nTPM
- myeloid DC: 18 nTPM
Brain region
- cerebral cortex: 21 nTPM
- hippocampal formation: 21 nTPM
- basal ganglia: 20 nTPM
- thalamus: 19 nTPM
- amygdala: 19 nTPM
- midbrain: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 0.99
- gnomAD missense Z
- -0.04
- DepMap mean gene effect
- -0.9
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- nuclear-transcribed mRNA catabolic process
- ribosomal large subunit assembly
- ribosomal large subunit biogenesis
- rRNA processing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Large ribosomal subunit protein uL10, N-terminal
- Large ribosomal subunit protein uL10-like, insertion domain
- Large ribosomal subunit protein uL10-like domain superfamily
- Large ribosomal subunit protein uL10-like, insertion domain superfamily
- Ribosomal protein L10
- Insertion domain in 60S ribosomal protein L10P
- Ribosome assembly factor Mrt4
- Ribosomal Assembly Factor uL10
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MRTO4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- MINAS-60
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MRTO4 as an antibody target. Whether an autoantibody or antibody against MRTO4 could matter depends on whether native MRTO4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MRTO4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MRTO4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...